Advanced Biomed Inc. (ADVB) vs iSpecimen Inc. (ISPC)
Advanced Biomed Inc. and iSpecimen Inc. are both Diagnostics & Research companies. Advanced Biomed Inc. is the larger, with a market value of $10.4M against $3.1M — 3.3× the size. iSpecimen Inc. has negative trailing earnings, so its P/E is not meaningful; Advanced Biomed Inc. trades at 1.3×. Advanced Biomed Inc. has the higher net margin (0.00% vs −2,449.0%) and the lower return on invested capital (−29.3% vs 0.00%). Across the 12 metrics below, Advanced Biomed Inc. leads on 9 and iSpecimen Inc. on 3.
Valuation
Profitability
| Metric | ADVB | ISPC | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | — | (108.26%) | 50.89% |
| Operating margin | 0.00% | (2,020.05%) | (8.57%) |
| Net margin | 0.00% | (2,449.02%) | (6.37%) |
| Free cash flow margin | 0.00% | (1,866.61%) | 0.00% |
| Return on equity | 79.17% | (968.44%) | (2.92%) |
| Return on assets | 55.78% | (170.09%) | (6.71%) |
| Return on invested capital | (29.27%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack